Particle.news

Download on the App Store

Kennedy Removes Thimerosal From U.S. Flu Vaccines as Medical Groups and States Forge Alternative Guidance

Approving a handpicked panel’s recommendation to ban thimerosal without CDC signoff, Kennedy has prompted leading medical organizations alongside several states to craft independent vaccine guidelines for the upcoming fall respiratory season.

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. speaks at a Make Oklahoma Healthy Again kickoff event at the Oklahoma State Capitol in Oklahoma City, Oklahoma, U.S. June 26, 2025. REUTERS/Nick Oxford/File Photo
Image
Image
Robert F. Kennedy Jr., the nephew of former U.S. President John F. Kennedy, gestures as he speaks to the crowd during a demonstration against coronavirus disease (COVID-19) vaccinations, in Milan, Italy, November 13, 2021. REUTERS/Flavio Lo Scalzo

Overview

  • On July 23, HHS Secretary Robert F. Kennedy Jr. officially signed a directive requiring all U.S. influenza vaccines to be single-dose and free of the mercury-based preservative thimerosal.
  • Vaccine manufacturers assured HHS that they can replace multidose vials without disrupting supplies for both adult immunizations and the Vaccines for Children program this season.
  • The absence of a Senate-confirmed CDC director allowed Kennedy to bypass the traditional agency approval process and enact the thimerosal ban directly.
  • The American Academy of Pediatrics, the American College of Obstetricians and Gynecologists and the Infectious Diseases Society of America announced plans to publish their own evidence-based flu vaccine guidelines this fall.
  • Several states, including Colorado and Massachusetts, are moving to rewrite immunization statutes to incorporate recommendations from medical societies alongside or in place of federal advisory guidance.